Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
Certara to report third quarter 2025 financial results on November 6th, 2025. Company management to…
CertaraOctober 10, 2025
RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging
Access our on-demand webinar and explore proven strategies to develop consistent, high-impact regulatory submission messages.
CertaraOctober 9, 2025
Certara IQ™ Fact Sheet
Certara IQ is the AI-enabled QSP modeling tool that will transform your research & scale…
CertaraOctober 8, 2025
MBMA vs. Meta-Analysis: Quick Comparison Guide
Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…
CertaraOctober 8, 2025
Alzheimer’s Disease Clinical Trials and Drug Development: Building a Robust Clinical Pharmacology & Model-Informed Strategy
Rajesh Krishna proposes using an integrated clinical pharmacology & model-informed strategy for Alzheimer's disease clinical…
CertaraOctober 7, 2025
Get clear, practical answers to the top 5 safety reporting questions & learn how to…
CertaraOctober 7, 2025
U.S. International Reference Pricing: Global Implications and Pharma Strategy
Unintended global fallout of international reference pricing: How the U.S. Most Favored Nation policy could…
CertaraOctober 6, 2025
